MODIFICATION
A -- Preclinical Medications Discovery and Abuse Liability Testing for NIDA - Amendment 2
- Notice Date
- 10/12/2016
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 3155, MSC 9593, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-17-8932
- Archive Date
- 8/31/2016
- Point of Contact
- Mark E. McNally, Phone: 301.443.6677, Kenneth Goodling, Phone: 301.443.6677
- E-Mail Address
-
mark.mcnally@nih.gov, kgoodlin@nida.nih.gov
(mark.mcnally@nih.gov, kgoodlin@nida.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Amendment No. 02 to answer questions regarding the RFP.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-17-8932/listing.html)
- Place of Performance
- Address: National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN04302366-W 20161014/161012234751-730027f503ecbe3c4fd8b82c3e0f19aa (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |